Cytomegalovirus pneumonia in adults with leukemia: An emerging problem

Clinical Infectious Diseases

Volumn 32, Issue 4, 2001, Pages 539-545

  Nguyen, Q ^a   Estey, E ^a   Raad, I ^a   Rolston, K ^a   Kantarjian, H ^a   Jacobson, K ^a   Konoplev, S ^a   Ghosh, S ^a   Luna, M ^a   Tarrand, J ^a   Whimbey, Estella ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; FOSCARNET; GANCICLOVIR; HEMOPOIETIC GROWTH FACTOR; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; EXPERIENCE; FEMALE; GRANULOCYTE TRANSFUSION; HOSPITALIZATION; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; T LYMPHOCYTE ACTIVATION; VIRUS PNEUMONIA;

ADULT; CYTOMEGALOVIRUS INFECTIONS; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOID; MIDDLE AGED; PNEUMONIA, VIRAL;

EID: 0035864507     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318721     Document Type: Article

References (41)

1. Recovery of cytomegalovirus from adults with neoplastic disease
2. Cytomegalovirus inclusion disease at autopsy of patients with cancer
3. Pulmonary complications in patients with adult T-cell leukemia
4. Cytomegalovirus infections in adult T-cell leukemia patients
5. Pathology of the lung in leukemia and lymphoma: A study of 87 autopsies
6. Lethal infections in patients with hematological malignancies
7. Autopsy findings in 47 cases of adult T-cell leukemia/lymphoma in Miyazaki Prefecture, Japan
8. Ten year survey of incidence of infection as a cause of death in hematologic malignancies: Study of 90 autopsied cases
9. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: Review of 20 cases occurring from 1964 through 1990
10. Infections in heamatological malignancies: An autopsy study of 72 cases
11. Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndromes
12. Fludarabine: A new agent with major activity against chronic lymphocytic leukemia
13. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor
14. Purine nucleoside analogs: Emerging roles in indolent lymphoproliferative disorders
15. Granulocyte transfusions from GM-CSF treated donors as infection prophylaxis in AML/MDS during induction
16. Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia
17. Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukemia
18. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia
19. Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone
20. Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine
21. Phase II trial of fludarabine phosphate in lymphoma: An effective new agent in low-grade lymphoma
22. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia and multivariate analysis-derived prognostic model for response to treatment
23. Fludarabine therapy for lymphoid malignancies is associated with a high number of opportunistic pulmonary infections
24. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukaemia
25. Severe immunodeficiency in patients treated with fludarabine monophosphate
26. Late listeriosis after fludarabine plus prednisone treatment
27. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas
28. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: A role for Pneumocystis carinii pneumonia prophylaxis
29. Infectious and immunosuppressive complications of purine analog therapy
30. Listeriosis after fludarabine treatment for chronic lymphocytic leukemia
31. Infections in patients with chronic lymphocytic leukemia treated with fludarabine
32. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody. CAMPATH-1H
33. Phase II multicenter study of human CD 52 antibody in previously treated chronic lymphocytic leukemia
34. Cytomegalovirus infections associated with leukocyte transfusions
35. The effect of granulocyte transfusions upon the incidence of cytomegalovirus infection after allogeneic marrow transplantation
36. Cytomegalic inclusion disease in patients with acute leukemia
37. Asymptomatic cytomegalovirus infection in children with leukemia
38. Cytomegalovirus infections during acute childhood leukemia
39. Cytomegaloviremia in children with acute lymphocytic leukemia
40. The importance of primary cytomegalovirus infection in childhood cancer
41. Cytomegalovirus infection in children with blood diseases